KALA BIO
KALA
KALA
96 hedge funds and large institutions have $353M invested in KALA BIO in 2020 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.21% more ownership
Funds ownership: 1.27% → 1.47% (+0.21%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
56% less call options, than puts
Call options by funds: $6.5M | Put options by funds: $14.8M
Holders
96
Holding in Top 10
2
Calls
$6.5M
Puts
$14.8M
Top Buyers
| 1 | +$55.7M | |
| 2 | +$26M | |
| 3 | +$25.1M | |
| 4 |
O
OrbiMed
New York
|
+$17.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.97M |
Top Sellers
| 1 | -$4.65M | |
| 2 | -$1.97M | |
| 3 | -$1.89M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.65M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.14M |